Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 12, Pages 3280-3289
Publisher
American Society of Hematology
Online
2011-06-29
DOI
10.1182/blood-2011-01-333039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
- (2010) Áine C. Murphy et al. BRAIN BEHAVIOR AND IMMUNITY
- Peripheral Neuropathy in Chronic Obstructııve Pulmonary Dıısease
- (2010) Çağğatay Öncel et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Kinase inhibitors: a new approach to rheumatoid arthritis treatment
- (2010) Stanley Cohen et al. CURRENT OPINION IN RHEUMATOLOGY
- KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase
- (2010) Antonio Garrido Montalban et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Kinetics of IL-17- and interferon-γ-producing PLPp-specific CD4 T cells in EAE induced by coinjection of PLPp/IFA with pertussis toxin in SJL mice
- (2010) Harald H. Hofstetter et al. NEUROSCIENCE LETTERS
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy
- (2009) R E Alten et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies
- (2009) Nemanja Damjanov et al. ARTHRITIS AND RHEUMATISM
- T Cell Receptor-mediated Activation of p38α by Mono-phosphorylation of the Activation Loop Results in Altered Substrate Specificity
- (2009) Paul R. Mittelstadt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Randomized, Placebo-Controlled Study of the Effects of the p38 MAPK Inhibitor SB-681323 on Blood Biomarkers of Inflammation in COPD Patients
- (2009) Dave Singh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic disruption of p38 Tyr323 phosphorylation prevents T-cell receptor-mediated p38 activation and impairs interferon- production
- (2008) L. Jirmanova et al. BLOOD
- Systematic review to establish the safety profiles for direct and indirect inhibitors of p38 Mitogen-activated protein kinases for treatment of cancer
- (2008) J. Kay Noel et al. MEDICAL ONCOLOGY
- Epigallocatechin-3-gallate suppresses TNF-α -induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts
- (2008) Hee-Jin Yun et al. RHEUMATOLOGY INTERNATIONAL
- The identification of a small molecule inhibitor that specifically reduces T cell-mediated adaptive but not LPS-mediated innate immunity by T cell membrane–monocyte contact bioassay
- (2007) Yi-Yang Yvonne Li et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started